1. Mohan G, Hanrahan CF, Martinez-Amezcua P, Hoffmann CJ, et al.
   Multidimensional Poverty and Implementation Reach of Household Contact Tracing for Tuberculosis in South Africa: Analysis of a Randomized Trial.
   Clin Infect Dis 2026.
   


2. Nicolls S, McClymont E, Lee M, Coutlee F, et al.
   Incidence and Prevalence of Human Papillomavirus Infection to Predict Outcomes from HPV-Based Cervical Cancer Screening in Women and People with a Cervix Living with HIV.
   J Acquir Immune Defic Syndr 2026.
   


3. Osman F, Yende-Zuma N, Zewotir T, Naicker N, et al.
   Comparing clinical and cytokine profiling of genital inflammation as predictors of HIV acquisition in women.
   J Acquir Immune Defic Syndr 2026.
   


4. Lertamornkitti N, Pheerapanyawaranun C, Le ON, Nallusamy RA, et al.
   Clinical Characteristics of Adolescents and Youth Living with HIV Transitioning from Pediatric to Adult Clinics Before and After 18 Years in Asia.
   J Acquir Immune Defic Syndr 2026.
   


5. Reid MJA, Sturke R, Vorkoper S, Kanyike A, et al.
   Brief Report: Closing the Implementation Gap: Prioritizing Rapid Science for Global HIV Impact.
   J Acquir Immune Defic Syndr 2026;101:756-759.
   


6. Ismail A, Njau P, Wang A, Kailembo A, et al.
   Population Viral Load Suppression and Associated Factors in Tanzania: Findings From 2 Sequential Tanzania HIV Impact Surveys of 2016-2017 and 2022-2023.
   J Acquir Immune Defic Syndr 2026;101:733-739.
   


7. Hotchkiss RS, Monneret G.
   Host-directed immune therapies: a second front in the battle against sepsis.
   J Clin Invest 2026;136.
   


8. Riggs PK, Honerkamp-Smith G, Meneses M, Caballero G, et al.
   CMV IgG and EBV Cell-Associated DNA Independently Associate With Veterans Aging Cohort Study (VACS) Index 2.0 Scores in People With HIV on Antiretroviral Therapy.
   J Infect Dis 2026.
   


9. Lichtner M, Vita S.
   CMV and EBV: a dynamic, powerful, and dangerous duo in PLWH.
   J Infect Dis 2026.
   


10. Louine M, Dandekar R, Reddy SP, Karalius MC, et al.
    Cerebrospinal fluid transcriptional immune pathways linked to survival in HIV-associated tuberculous meningitis.
    J Infect Dis 2026.
    


11. Li W, Jin L, Qing Y, Rang Z, et al.
    Evidence of Intestinal Barrier Dysfunction in Asymptomatic HIV Infection via the NLRP3/Caspase-1/GSDMD Pyroptosis Pathway.
    J Med Virol 2026;98:e71020.
    


12. Moriarty RV, Harwood OE, Johnson EP, Gardner W, et al.
    CD8a+ cells suppress SIV replication without the development of mutations within MHC class-I-restricted epitopes during post-treatment control.
    J Virol 2026.
    


13. Lee TC, Barina LA, Walls G, Goodman AL, et al.
    Cefazolin for Methicillin-Susceptible Staphylococcus aureus Bacteremia.
    N Engl J Med 2026;394:2329-2339.
    


14. Binley J.
    An HIV vaccine blueprint.
    Science 2026;392:1241-1242.
    

Display articles in

• Abstract format